Cardio-Cerebrovascular Most Recent
MD, CCFP, FRCPC
MD, PhD, CRCP(C)
Choosing the optimal first-line drug for patients with hypertension must address a hierarchy of treatment goals...
It is as important to treat hypertension in older adults as it is in younger people.
Low bone mineral density (BMD) is associated with obstructive coronary artery disease (CAD); this article reviews several recent studies that have demonstrated the association.
Randomized, double-blind, placebo-controlled studies and observational studies have documented that statins reduce mortality and major cardiovascular events in high-risk persons with hypercholesterolemia.
Atrial fibrillation (AF) is by the far the most common cardiac rhythm disturbance encountered in clinical practice.
Treating Hypertension in the Very Elderly Reduces Death and Disability: New Information from the HYVET Trial
The World Health Organization has named hypertension the leading risk for death globally in adults.
For those with persistent gait and upper limb deficits after stroke, it is difficult to obtain recovery of motor control and functional capability in response to standard care methods.
Orthostatic hypotension (OH), while not itself a disease, is an important physical finding in the setting of unexplained syncope or falls.
Dual Antiplatelet Therapy for Cardiovascular Protection: Indication, Duration, and Other Considerations
Dual antiplatelet therapy (DAT) with acetylsalicylic acid and a thienopyridine agent (clopidogrel) as secondary prevention for patients with atherosclerotic coronary artery disease has been proven effective in those with unstable angina or acute coronary syndromes and following a percutaneous coronary intervention.